Global Nebulizers Market Report 2019: The Market is 2018 was Worth $708 Million, and is Forecast to Reach $1.07 Billion by 2024 -

DUBLIN--()--The "Nebulizers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to's offering.

The global nebulizers market was worth US$ 708.2 Million in 2018

Nebulizers are devices that are used by patients suffering from respiratory diseases to administer the medication directly into the lungs. Usually made up of a motor, mouthpiece, cup and tubing, these devices turn liquid medicine into a fine mist by using oxygen, compressed air or ultrasonic power for breaking up the liquid drug into aerosols.

They are prescribed by doctors to people who are unable to breathe deeply while using an inhaler. Nebulizers are primarily utilized for providing relief from extreme breathing conditions such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, etc.

Rising prevalence of chronic respiratory diseases is a major factor boosting the growth of the market. Busy schedules, sedentary lifestyles and a lack of physical activities have led to an increase in prevalence of obesity across the globe. This, in confluence with escalating consumption of tobacco and alcohol, is significantly contributing to the increasing occurrence of respiratory disorders, thereby bolstering the sales of nebulizers.

Apart from this, rising pollution levels on account of increasing adoption of private vehicles and expansion of industries is another key factor that is contributing to the product's demand globally. Moreover, the growing geriatric population has led to an increase in the demand for home healthcare devices, which is driving the demand for portable variants.

Furthermore, several organizations are taking initiatives to spread awareness about the available treatment options for respiratory diseases. For instance, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) is actively educating the public about the risks posed by COPD and the treatment of the same.

The market to reach a value of US$ 1,074.8 Million by 2024, registering a CAGR of around 7% during 2019-2024.

Key Questions Answered in This Report:

  • How has the global nebulizers market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global nebulizers industry?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the portability?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the global nebulizers industry?
  • What are the key driving factors and challenges in the global nebulizers industry?
  • What is the structure of the global nebulizers industry and who are the key players?
  • What is the degree of competition in the global nebulizers industry?
  • What are the profit margins in the nebulizers industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.4 Market Estimation

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Nebulizers Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Breakup by Product Type

5.4 Market Breakup by Portability

5.5 Market Breakup by End-User

5.6 Market Breakup by Application

5.7 Market Breakup by Region

5.8 Market Forecast

6 Market Breakup by Product Type

6.1 Pneumatic Nebulizers

6.2 Ultrasonic Nebulizers

6.3 Mesh Nebulizers

6.4 Others

7 Market Breakup by Portability

7.1 Portable Nebulizers

7.2 Standalone Nebulizers

8 Market Breakup by End-User

8.1 Hospitals and Clinics

8.2 Long Term Healthcare Centers

8.3 Homecare Settings

8.4 Outpatient Settings

9 Market Breakup by Application

9.1 COPD

9.2 Cystic Fibrosis

9.3 Asthma

9.4 Others

10 Market Breakup by Region

11 SWOT Analysis

11.1 Overview

11.2 Strengths

11.3 Weaknesses

11.4 Opportunities

11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview

13.2 Bargaining Power of Buyers

13.3 Bargaining Power of Suppliers

13.4 Degree of Competition

13.5 Threat of New Entrants

13.6 Threat of Substitutes

14 Price Analysis

14.1 Key Price Indicators

14.2 Price Structure

14.3 Margin Analysis

15 Competitive Landscape

15.1 Market Structure

15.2 Key Players

15.3 Profiles of Key Players

15.3.1 Briggs Healthcare

15.3.2 Ca-Mi

15.3.3 Besco Medical

15.3.4 Flyp

15.3.5 De Vilbiss Healthcare

15.3.6 Omron

15.3.7 Becton Dickinson

15.3.8 Koninklijke Philips N.V.

15.3.9 Feellife Health

15.3.10 Invacare

15.3.11 Pari Medical

15.3.12 Philips Respironics

15.3.13 Agilent Technologies

15.3.14 Medline Industries

15.3.15 GF Health Products

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900